Pharmaceutical tariffs still in play despite Supreme Court ruling
2026-02-20 15:21:00 ET
More on pharmaceutical companies
- Q4 Healthcare Dividends: Johnson & Johnson Kept Outshining Pfizer (Rating Upgrades)
- Eli Lilly Trumps Novo Nordisk In GLP-1 Race: Multi-Year Growth Prospects
- Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game
- Moderna sued for violating patent linked to Pfizer/ BioNTech COVID-19 shot
- CDC said to delay vaccine panel meeting after lawsuit challenging its composition
Read the full article on Seeking Alpha
For further details see:
Pharmaceutical tariffs still in play despite Supreme Court rulingNASDAQ: RHHBY
RHHBY Trading
-2.37% G/L:
$50.70 Last:
1,323,065 Volume:
$51.31 Open:



